ABCC11
protein-codingATP binding cassette subfamily C member 11, the group of ATP binding cassette subfamily C
Gene summary
The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This ABC full transporter is a member of the MRP subfamily which is involved in multi-drug resistance. The product of this gene participates in physiological processes involving bile acids, conjugated steroids, and cyclic nucleotides. In addition, a SNP in this gene is responsible for determination of human earwax type. This gene and family member ABCC12 are determined to be derived by duplication and are both localized to chromosome 16q12.1. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~81.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: The clinical relevance is unclear
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ABCC11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001370497.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 4 | 10 | ||
| missense | 203 | 27 | 5 | 235 | ||
| nonsense | 1 | 1 | 2 | |||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 0 | 0 | 208 | 33 | 9 | 250 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001357426.1 | 29 | MANE Select | |
| Ensembl | ENSP00000349017.2 | 29 | MANE Select | |
| RefSeq | NP_001357425.1 | 29 | Standard | |
| RefSeq | NP_115972.2 | 29 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- ABC transporters - Homo sapiens (human)
- Androgen and estrogen biosynthesis and metabolism
- Transport of small molecules
- ABC-family proteins mediated transport
Biological Process
- organic anion transport
- purine nucleotide transport
- transmembrane transport
- ATP hydrolysis coupled anion transmembrane transport
Molecular Function
- ATP binding
- organic anion transmembrane transporter activity
- purine nucleotide transmembrane transporter activity
- ATPase activity, coupled to transmembrane movement of substances
- ATPase-coupled anion transmembrane transporter activity
Cellular Component
- vacuolar membrane
- plasma membrane
- integral component of plasma membrane
- membrane
- cytoplasmic vesicle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000394747
- Coding exons
- 29
- Length
- 80659
- Individuals with no LoFs
- 122222
- Homozygous LoFs
- 21
- Heterozygous LoFs
- 3505
- Defined
- 125748
- p
- 0.0141
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.197 | 809 | 793 | 1.02 | 0.0000447 | 9012 |
| Missense (PolyPhen) | 223 | 238.74 | 0.93405 | 2902 | ||
| Synonymous | -0.304 | 332 | 325 | 1.02 | 0.0000196 | 2761 |
| Loss of Function | -0.0885 | 69 | 68.2 | 1.01 | 0.00000345 | 788 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0055 | 0.0054 | notable |
| Latino/Admixed American | 0.014 | 0.014 | notable |
| Ashkenazi Jewish | 0.019 | 0.019 | notable |
| East Asian | 0.0023 | 0.0023 | notable |
| Finnish | 0.012 | 0.012 | notable |
| European (Non-Finnish) | 0.020 | 0.020 | notable |
| South Asian | 0.0024 | 0.0024 | notable |
| Other | 0.017 | 0.017 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Participates in physiological processes involving bile acids, conjugated steroids and cyclic nucleotides (PubMed:12764137, PubMed:15537867). Enhances the cellular extrusion of cAMP and cGMP (PubMed:12764137, PubMed:15537867). Stimulates the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S- conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-beta-D- glucuronide (E(2)17betaG), the monoanionic bile acids glycocholate and taurocholate, and methotrexate (PubMed:15537867, PubMed:25896536). Probably functions to secrete earwax (PubMed:16444273, PubMed:19383836). Required for the secretion of components contributing to axillary odor formation (PubMed:19710689). {ECO:0000269|PubMed:12764137, ECO:0000269|PubMed:15537867, ECO:0000269|PubMed:16444273, ECO:0000269|PubMed:19383836, ECO:0000269|PubMed:19710689, ECO:0000269|PubMed:25896536}.;
Recessive Scores
- pRec
- 0.701
Intolerance Scores
- LoFtool
- 0.0152
- RVIS EVS
- 1.62
- RVIS percentile EVS
- 96.04
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.270
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |